Nanjing Chang'ao Pharmaceutical Technology

Nanjing Chang'ao Pharmaceutical Technology is a specialized pharmaceutical research and development company headquartered in Nanjing, China. Founded in 2011, the firm focuses on the development of high-end generic drugs and innovative small molecule therapeutics across several key therapeutic areas, including cardiovascular, central nervous system, and gastrointestinal diseases. The company provides comprehensive R&D services, including drug synthesis, formulation development, and consistency evaluation, which is critical for the Chinese regulatory landscape. Chang'ao operates advanced laboratory facilities and has successfully brought multiple generic products to the commercial stage through partnerships with major domestic manufacturers. Their strategic focus combines the immediate market needs for high-quality generics with long-term investment in novel drug discovery.